NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezuelan Population

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Fernández Mestre, Mercedes ^a   Villasmil, Ángel ^a   Takiff, Howard ^b   Fuentes Alcalá, Zhenia ^c  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Instituto Venezolano de Investigaciones Cientificas Centro de Microbiologia y Biologia Celular   (Venezuela)

^c Dr José Ignacio Baldó Hospital   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

APAI PROTEIN; FOKI PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROTEIN; TAQI PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; 3' UNTRANSLATED REGION; CALCITRIOL RECEPTOR; CATION TRANSPORT PROTEIN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; VDR PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; VENEZUELAN; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; TUBERCULOSIS;

EID: 84947983489     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/860628     Document Type: Article

References (46)

1. World Health Organization, Global Tuberculosis Report, 2014, World Health Organization, Geneva, Switzerland, 2014.
2. F. Wu, W. Zhang, L. Zhang et al., "NRAMP1, VDR, HLADRB1, and HLA-DQB1 gene polymorphisms in susceptibility to tuberculosis among the Chinese kazakh population: a casecontrol study," BioMed Research International, vol. 2013, Article ID 484535, 8 pages, 2013.
3. M. Bunce, "PCR-SSP typing in histocompatibility testing," in Bidwell and Navarrette C, pp. 149-186, Imperial Collage Press, London, UK, 2000.
4. C. A. Taype, J. C. Castro, R. A. Accinelli, P. Herrera-Velit, M. A. Shaw, and J. R. Espinoza, "Association between SLC11A1 polymorphisms and susceptibility to different clinical forms of tuberculosis in the Peruvian population," Infection, Genetics and Evolution, vol. 6, no. 5, pp. 361-367, 2006.
5. J. E. Curran, T. Vaughan, R. A. Lea, S. R. Weinstein, N. A. Morrison, and L. R. Griffiths, "Association of a vitaminDreceptor polymorphism with sporadic breast cancer development," International Journal of Cancer, vol. 83, no. 6, pp. 723-726, 1999.
6. A. Svejgaard and L. P. Ryder, "HLA and disease associations: detecting the strongest association," Tissue Antigens, vol. 43, no. 1, pp. 18-27, 1994.
7. B. Woolf, "On estimating the relation between blood group and disease," Annals of Human Genetics, vol. 19, no. 4, pp. 251-253, 1955.
8. N. Arji, M. Busson, G. Iraqi et al., "Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in moroccan patients," Journal of Infection in Developing Countries, vol. 8, no. 4, pp. 430-440, 2014.
9. M. Y. Areeshi, R. K. Mandal, A. K. Panda, and S. Haque, "Vitamin D receptor apai gene polymorphism and tuberculosis susceptibility: a meta-analysis," Genetic Testing and Molecular Biomarkers, vol. 18, no. 5, pp. 323-329, 2014.
10. L. Joshi, M. Ponnana, S. R. Penmetsa, P. Nallari, V. Valluri, and S. Gaddam, "Serum vitamin D levels and VDR polymorphisms (BsmI and FokI) in patients and their household contacts susceptible to tuberculosis," Scandinavian journal of immunology, vol. 79, no. 2, pp. 113-119, 2014.
11. C. Chen, Q. Liu, L. Zhu, H. Yang, and W. Lu, "Vitamin D receptor gene polymorphisms on the risk of tuberculosis, a meta-analysis of 29 case-control studies," PLoS ONE, vol. 8, no. 12, Article ID e83843, 2013.
12. Y.-J. Wu, X. Yang, X.-X. Wang et al., "Association of vitamin D receptor BsmI gene polymorphism with risk of tuberculosis: a meta-analysis of 15 studies," PLoS ONE, vol. 8, no. 6, Article ID e66944, 2013.
13. A. Simon-Gruita, G. Duta Cornescu, N. Constantin, M. D. Pojoga, T. Saitan, andV. Stoian, "Apa I andTaq I polymorphisms of VDR (vitamin D receptor) gene in association with susceptibility to tuberculosis in the Romanian population," Romanian Biotechnological Letters, vol. 8, no. 1, pp. 7956-7962, 2013.
14. O. Ates, B. Dolek, L. Dalyan, B. Musellim, G. Ongen, and A. Topal-Sarikaya, "The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis," Molecular Biology Reports, vol. 38, no. 4, pp. 2633-2636, 2011.
15. S. M. Marashian, P. Farnia, S. Seyf, S. Anoosheh, and A. A. Velayati, "Evaluating the role of vitamin D receptor polymorphisms on susceptibility to tuberculosis among Iranian patients: a case-control study," Tüberküloz ve Toraks, vol. 58, no. 2, pp. 147-153, 2010.
16. L. Gao, Y. Tao, L. Zhang, andQ. Jin, "VitaminDreceptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis," The International Journal of Tuberculosis and Lung Disease, vol. 14, no. 1, pp. 15-23, 2010.
17. Z.-Z. Zhao, T.-Z. Zhang, Y.-M. Gao, and F.-M. Feng, "Metaanalysis of relationship of vitamin D receptor gene polymorphism and tuberculosis susceptibility," Zhonghua Jie He He Hu Xi Za Zhi, vol. 32, no. 10, pp. 748-751, 2009.
18. M. Merza, P. Farnia, S. Anoosheh et al., "The NRAMPI, VDR and TNF-α gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility," Brazilian Journal of Infectious Diseases, vol. 13, no. 4, pp. 252-256, 2009.
19. R. Olesen, C. Wejse, D. R. Velez et al., "DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk inWest Africans," Genes and Immunity, vol. 8, no. 6, pp. 456-467, 2007.
20. A.K. Wilbur, L. S. Kubatko, A.M. Hurtado, K. R. Hill, andA.C. Stone, "Vitamin D receptor gene polymorphisms and susceptibility M. tuberculosis in Native Paraguayans," Tuberculosis, vol. 87, no. 4, pp. 329-337, 2007.
21. Z. Lombard, D.-L. Dalton, P. A. Venter, R. C. Williams, and L. Bornman, "Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa," Human Immunology, vol. 67, no. 8, pp. 643-654, 2006.
22. L. Bornman, S. J. Campbell, K. Fielding et al., "Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study," The Journal of Infectious Diseases, vol. 190, no. 9, pp. 1631-1641, 2004.
23. W. Liu, W.-C. Cao, C.-Y. Zhang et al., "VDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control study," The International Journal of Tuberculosis and Lung Disease, vol. 8, no. 4, pp. 428-434, 2004.
24. P. Selvaraj, G. Chandra, S. M. Kurian, A.M. Reetha, and P. R. Narayanan, "Association of vitamin D receptor gene variants of BsmI, ApaI and FokI polymorphisms with susceptibility or resistance to pulmonary tuberculosis," Current Science, vol. 84, no. 12, pp. 1564-1568, 2003.
25. R. J. Wilkinson, M. Llewelyn, Z. Toossi et al., "Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a casecontrol study," The Lancet, vol. 355, no. 9204, pp. 618-621, 2000.
26. R. Bellamy, C. Ruwende, T. Corrah et al., "Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene," The Journal of Infectious Diseases, vol. 179, no. 3, pp. 721-724, 1999.
27. B. Y. Sinaga, M. Amin, Y. Siregar, and S. M. Sarumpaet, "Correlation between vitamin D receptor gene FOKI and BSMI polymorphisms and the susceptibility to pulmonary tuberculosis in an indonesian batak-ethnic population," Acta Medica Indonesiana, vol. 46, no. 4, pp. 275-282, 2014.
28. M. Y. Areeshi, R. K. Mandal, N. Akhter, A. K. Panda, and S. Haque, "Evaluating the association between taqi variant of vitamin D receptor gene and susceptibility to tuberculosis: a meta-analysis," Toxicology International, vol. 21, no. 2, pp. 140-147, 2014.
29. T. J. Kang, S. H. Jin, C. E. Yeum et al., "Vitamin D receptor gene TaqI, BsmI and FokI polymorphisms in Korean patients with tuberculosis," Immune Network, vol. 11, no. 5, pp. 253-257, 2011.
30. S. J. Lewis, I. Baker, and G. D. Smith, "Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk," International Journal of Tuberculosis and Lung Disease, vol. 9, no. 10, pp. 1174-1177, 2005.
31. J. C. Delgado, A. Baena, S. Thim, and A. E. Goldfeld, "Ethnicspecific genetic associations with pulmonary tuberculosis," The Journal of Infectious Diseases, vol. 186, no. 10, pp. 1463-1468, 2002.
32. F. Canonne-Hergaux, S. Gruenheid, G. Govoni, and P. Gros, "The Nramp1 protein and its role in resistance to infection and macrophage function," Proceedings of the Association of American Physicians, vol. 111, no. 4, pp. 283-289, 1999.
33. S. Searle and J. M. Blackwell, "Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility," Journal of Medical Genetics, vol. 36, no. 4, pp. 295-299, 1999.
34. R. Bellamy, "NRAMP and susceptibility to tuberculosis," The International Journal of Tuberculosis and Lung Disease, vol. 6, no. 9, p. 747, 2002.
35. R. Bellamy, C. Ruwende, T. Corrah, K. P. W. J. McAdam, H. C. Whittle, and A. V. S. Hill, "Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans," The New England Journal ofMedicine, vol. 338, no. 10, pp. 640-644, 1998.
36. S. Ryu, Y.-K. Park, G.-H. Bai, S.-J. Kim, S.-N. Park, and S. Kang, "3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans," International Journal of Tuberculosis and Lung Disease, vol. 4, no. 6, pp. 577-580, 2000.
37. F. Wu, W. Zhang, L. Zhang et al., "NRAMP1, VDR, HLADRB1, and HLA-DQB1 gene polymorphisms in susceptibility to tuberculosis among the Chinese Kazakh population: a casecontrol study," BioMed Research International, vol. 2013, Article ID 484535, 8 pages, 2013.
38. Y.-S. Liaw, J.-J. Tsai-Wu, C.-H. Wu et al., "Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese," International Journal of Tuberculosis and Lung Disease, vol. 6, no. 5, pp. 454-460, 2002.
39. S. Vejbaesya, N. Chierakul, P. Luangtrakool, and C. Sermduangprateep, "NRAMP1andTNF-α polymorphisms and susceptibility to tuberculosis in Thais," Respirology, vol. 12, no. 2, pp. 202-206, 2007.
40. J. El Baghdadi, N. Remus, A. Benslimane et al., "Variants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco," International Journal of Tuberculosis and Lung Disease, vol. 7, no. 6, pp. 599-602, 2003.
41. C. Søborg, A. B. Andersen, H. O. Madsen, A. Kok-Jensen, P. Skinhøj, and P. Garred, "Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis," The Journal of Infectious Diseases, vol. 186, no. 4, pp. 517-521, 2002.
42. M. A. Shaw, A. Collins, C. S. Peacock et al., "Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA," Tubercle and Lung Disease, vol. 78, no. 1, pp. 35-45, 1997.
43. J. Nugraha and R. Anggraini, "NRAMP1 polymorphism and susceptibility to lung tuberculosis in Surabaya, Indonesia," Southeast Asian Journal of Tropical Medicine and PublicHealth, vol. 42, no. 2, pp. 338-341, 2011.
44. Y.-H. Hsu, C.-W. Chen, H. S. Sun, R. Jou, J.-J. Lee, and I.-J. Su, "Association of NRAMP 1 gene polymorphism with susceptibility to tuberculosis in Taiwanese aboriginals," Journal of the FormosanMedical Association, vol. 105, no. 5, pp. 363-369, 2006.
45. M. Nairz, D. Haschka, E. Demetz, and G. Weiss, "Iron at the interface of immunity and infection," Frontiers in Pharmacology, vol. 5, article 152, 10 pages, 2014.
46. J. M. McDermid and A.M. Prentice, "Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV," Clinical Science, vol. 110, no. 5, pp. 503-524, 2006.